GLP-1 medications: a medical advance that’s changing the conversation

glp-1 weight loss atlanta

Somerset Medical’s Dr. Nicholas Church featured on French national radio discussing America’s GLP-1 phenomenon and the future of weight management

  • Dr. Nicholas Church was recently interviewed by France Info, France’s national public radio network, in a segment exploring how GLP-1 medications such as Ozempic and Wegovy have become both a cultural and medical phenomenon across the United States.

  • In the discussion, he shared a physician’s perspective on how these medications—originally designed to treat diabetes—are helping many patients achieve safe, effective, and medically supervised weight loss.

  • Dr. Church emphasized that lasting results depend not just on the medication itself, but on combining it with education, nutrition, and sustainable lifestyle habits.

  • The feature article, “Tu choisis mieux ta nourriture : les médicaments anti-obésité deviennent de véritables phénomènes de société aux États-Unis” (translated: “You choose your food better: anti-obesity drugs are becoming true social phenomena in the U.S.”), explores how these treatments are reshaping both public attitudes and medical practice.

Share this post:

The France Info feature reflects a growing international curiosity about how the United States is handling a wave of new GLP-1-based medications such as semaglutide (Ozempic®, Wegovy®) and tirzepatide (Mounjaro®). These medications were developed to help people with type 2 diabetes manage blood sugar by mimicking the natural hormone GLP-1, which affects insulin response and appetite regulation.

As doctors began noticing their impact on weight loss, the focus broadened to include metabolic health, obesity management, and even the psychology of eating. The medications became mainstream almost overnight—featured on talk shows, in magazines, and across social media. Yet, as Dr. Church noted in his interview, the headlines often miss the most important part: these are powerful medical tools, not lifestyle shortcuts.

At Somerset Medical in Atlanta, Dr. Church sees firsthand how GLP-1 therapy can be transformative when used responsibly. “The excitement is understandable,” he explains, “but it’s vital that patients use these medications under proper supervision. The goal isn’t just losing weight—it’s restoring metabolic balance, improving energy, and creating a healthier relationship with food.”

Why physician guidance matters

Somerset Medical’s GLP-1 for Metabolic Health program was designed around that very idea. The program goes far beyond simply prescribing a medication. Each patient begins with a comprehensive assessment that includes:

  • A detailed health evaluation and lab testing to determine eligibility and identify any underlying conditions.
  • Personalized dosing and ongoing monitoring to adjust the treatment safely over time.
  • Lifestyle and nutrition coaching that turns short-term progress into long-term health.
  • Continuous access to Dr. Church and his care team, ensuring that patients never feel alone in the process.

This approach recognizes that weight loss and metabolic health are deeply interconnected. GLP-1 medications can help regulate appetite, stabilize blood sugar, and reduce inflammation—but they work best when paired with improved sleep, balanced nutrition, and stress management.

“Medication can open the door,” Dr. Church often says, “but real change happens when you walk through it with support.”

That philosophy echoes throughout Somerset Medical’s entire model of care. Whether treating executives managing stress and fatigue, LGBTQ+ patients seeking inclusive healthcare, or busy professionals struggling to prioritize themselves, Dr. Church’s concierge-style practice emphasizes simplicity, relationships, and respect. Patients appreciate that it never feels transactional—it feels human.

The global impact of the GLP-1 revolution

The France Info segment highlights a significant cultural moment: the conversation around obesity is shifting from blame and stigma to science and empathy. Across Europe and the U.S., more physicians are recognizing obesity as a chronic medical condition rather than a failure of willpower.

Dr. Church’s inclusion in the discussion underscores Somerset Medical’s position at the intersection of medicine and modern wellness. His experience aligns with what many European health experts are now exploring—how to integrate pharmacologic treatments with preventive care and personalized medicine.

“It’s encouraging to see international attention on this topic,” Dr. Church shared. “It shows we’re finally talking about weight in the context of health, not appearance. And that’s a shift we’ve needed for a long time.”

At Somerset Medical, the goal isn’t a number on the scale—it’s helping people feel confident, energized, and in control of their health. The weight management program incorporates GLP-1 therapy as one possible tool among many, guided by the same principles that define all Somerset care:

  • Honesty — Clear, transparent guidance about what to expect.
  • Expertise — Decades of primary-care experience behind every decision.
  • Simplicity — Direct communication and easy access to care.
  • Respect — Judgment-free support for every patient’s unique journey.

By combining evidence-based medicine with genuine human connection, Somerset Medical offers an alternative to the fragmented, rushed experience many patients have faced elsewhere.

The France Info feature shines a light on how American medicine is evolving—and how practices like Somerset Medical are leading that change from the ground up. Rather than chasing trends, Dr. Church is helping patients make sense of them, using trusted science and individualized care to achieve lasting results.

If you’re considering GLP-1 therapy or looking for a physician who can help you manage weight safely and effectively, learn more about Somerset Medical’s approach at https://somerset-medical.com/weight-loss/.

Read the full article (in French): France Info – Les médicaments anti-obésité deviennent de véritables phénomènes de société aux États-Unis